Company: SPEG
Filing Date: 2025-06-18
Form Type: CORRESP
Source: 0001213900-25-055714
Chunk: 1

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-06-18
Form: CORRESP
Chunk 1
---
 Hong Kong www.loeb.com

For the United States offices, a limited liability partnership including
professional corporations. For Hong Kong office, a limited liability partnership.

| 2. | Please clarify whether the potential indirect purchase of private placement warrants and founder shares by non-managing sponsor 
 investors is conditioned upon their purchase of units in the offering.                                                          |

Response: In response to the Staff’s
comment, the Company has revised the disclosure on the cover of the Amendment.

| 3. | Please disclose the number of non-managing sponsor members who have expressed an interest in purchasing units. Please disclose           
 whether there is a cap on the amount that each investor may purchase. Please also disclose that the non-managing sponsor investors will  
 have the potential to realize enhanced economic returns from their investment as compared to other investors purchasing in the offering. 
 Please also revise the summary to add back the disclosure regarding the expression of interest and further clarify the potential impact  
 such purchases could have upon the trading volume, volatility and liquidity.                                                             |

Response: In response to the Staff’s comment, the Company has revised the
disclosure on the cover, the summary and on page 153 of the Amendment.

| 4. | We note your disclosure that non-managing Sponsor investors will have no obligation to vote any of their public shares in favor                  
 of your initial business combination, but that if they purchase all of the public units in which they have expressed interest or otherwise       
 hold a substantial number of public units they will “potentially have different interests than our other public shareholders”                    
 in approving a business combination. It would appear that non-managing sponsor interests would have different interests than public shareholders 
 regardless of the number of public shares they own due to their interest in founder shares and private placement warrants. Please revise         
 to clarify here and throughout the prospectus where you state that non¬managing Sponsor investors have no obligation to vote any public          
 shares in favor of a business combination.                                                                                                       |

Response: In response to the Staff’s comment, the Company has revised the
disclosure on the cover and elsewhere in the Amendment.

Private Placements, page 14

| 5. | We note the disclosure regarding the ability of the Class B.2 warrant holders to exchange their warrants for common stock based          
 upon the formula provided. Please reconcile with the cover page which states that “each private placement warrant entitles the holder    
 thereof to purchase one Class A ordinary share at a price of $11.50 per share.” Please also provide some examples